ow-dose atropine eye drops to reduce progression of myopia in children: a multi-centre placebo controlled randomised trial in the United Kingdom (CHAMP UK) - Low-dose atropine eye drops for children with myopia in the UK

Belfast Health and Social Care Trust0 个研究点目标入组 289 人开始时间: 2018年8月29日最近更新: 2019年6月30日

适应症

试验速览

暂无简介。

•1.Age 6-12 years (at the time of consenting)
•2.Myopia of -0.5D or greater (spherical equivalent refractive error) in both eyes
•3.Best-corrected distance visual acuity (BCDVA) of 0.20 logMAR or better in both eyes
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 289
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range 0
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range 0

•1.Children with other ocular morbidities
•2.Myopia of -10D or greater in either eye
•3.Astigmatism of 2D or higher in either eye
•4.Amblyopia
•5.Significant health problems that can compromise the ability to attend research visits or complete the trial
•6.Other factors that may compromise the ability to attend the research appointments
•7.Parents or children with poor understanding of the English language
•8.Children enrolled in other interventional trials
•9.Allergy or hypersensitivity to atropine or excipients

发起方